Pandey, P.; Khan, F.; Qari, H.A.; Upadhyay, T.K.; Alkhateeb, A.F.; Oves, M.
Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4. Pharmaceuticals 2022, 15, 335.
https://doi.org/10.3390/ph15030335
AMA Style
Pandey P, Khan F, Qari HA, Upadhyay TK, Alkhateeb AF, Oves M.
Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4. Pharmaceuticals. 2022; 15(3):335.
https://doi.org/10.3390/ph15030335
Chicago/Turabian Style
Pandey, Pratibha, Fahad Khan, Huda A. Qari, Tarun Kumar Upadhyay, Abdulhameed F. Alkhateeb, and Mohammad Oves.
2022. "Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4" Pharmaceuticals 15, no. 3: 335.
https://doi.org/10.3390/ph15030335
APA Style
Pandey, P., Khan, F., Qari, H. A., Upadhyay, T. K., Alkhateeb, A. F., & Oves, M.
(2022). Revolutionization in Cancer Therapeutics via Targeting Major Immune Checkpoints PD-1, PD-L1 and CTLA-4. Pharmaceuticals, 15(3), 335.
https://doi.org/10.3390/ph15030335